IL17A and Hyperglycemia: In STZ-induced T1D, mice deficient in IL-17R (28) or IL-17 (29) are resistant to STZ-induced diabetes progression and exhibit reduced insulitis and hyperglycemia, indicating that IL-17 plays a pathogenic role in this model.